Gujarat Themis Biosyn Ltd Share Price

₹439.15 29.75 (7.27%) BSE
as updated on 24-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:411.00
  • Day's High:443.95

  • 52 Week Low192.35
  • 52 Week High479.45

Gujarat Themis Biosyn Ltd's key Fundamentals

Market Cap ₹4,461 Cr.
P/E Ratio 92.4
TTM EPS 4.4
P/B Ratio 16.87
ROE 21.67
Debt to Equity 0.12
Face Value 1
BVPS 24.3
3 Year Sales Growth 9.50%

Gujarat Themis Biosyn Ltd's Share Price Returns

1 Day 7.27%
1 Week 12.30%
1 Month 9.60%
3 Months 6.70%
6 Months 25.70%
1 Years 46.80%
3 Years 362.20%
5 Years 1148.60%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Gujarat Themis Biosyn Ltd Shareholding Pattern

Promoters

(70.86%)

Institutions

(4.12%)

Non-Institutions

(25.01%)

Pledged shares as % of Promoter's holding (%)

(3.30%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd, established in 1981, is a biotech and synthetic product manufacturing company, having plants at Vapi, Hyderabad, with group turnover of over $ 40 million. It has EDMFs, available and WHO approved plants.

The company has world-wide exports to satisfied customers, having customised facility for all products.

The company’s principal activity is to manufacture and distributes pharmaceuticals bulk drugs called rifampicin produced by fermentation process. The company's products include preparations of active pharmaceutical ingredient rifampicin and lovastatin. The company exports its products to Europe and the United States.

Kopran alongwith Cadila Healthcare Ltd., Lyka Labs Ltd., Themis Chemicals Ltd. and Anant & Co., formed Pharmaceutical Business Group (India) Ltd. in 1990.PBG acquired Gujarat Themis Biosyn Ltd (GTBL) as a sick company from BIFR in collaboration with Yuhan Corporation, South Korea and became India’s first producer of Rifampicin.Yuhan has provided technology for Rifampicin from fermentation and invested in equity also.

Business area of the company

  • Pharmaceuticals & Drugs
Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 411.00
  • Day's High: 443.95

  • 52 Week Low192.35
  • 52 Week High479.45

Gujarat Themis Biosyn Ltd's key Fundamentals

Market Cap ₹4,461 Cr.
P/E Ratio 92.4
TTM EPS 4.4
P/B Ratio 16.87
ROE 21.67
Debt to Equity 0.12
Face Value 1
BVPS 24.3
3 Year Sales Growth 9.50%

Gujarat Themis Biosyn Ltd's Share Price Returns

1 Day 7.27%
1 Week 12.30%
1 Month 9.60%
3 Months 6.70%
6 Months 25.70%
1 Years 46.80%
3 Years 362.20%
5 Years 1148.60%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×